The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 196.50
Bid: 196.00
Ask: 197.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.51%)
Open: 196.50
High: 196.50
Low: 192.00
Prev. Close: 196.50
FRAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Closing

23 Mar 2017 08:14

RNS Number : 2981A
Franchise Brands PLC
23 March 2017
 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT HAS NOT BEEN APPROVED BY THE LONDON STOCK EXCHANGE, NOR IS IT INTENDED THAT IT WILL BE SO APPROVED.

23 March 2017

Franchise Brands plc

("Franchise Brands", "the Group", or "the Company")

 

Results of proposed placing to raise £20 million

 

Further to the announcement made earlier today, the Board of Franchise Brands is pleased to announce the completion of a placing of 29,850,747 new ordinary shares of 0.5p each in the Company (the "Placing Shares") at a price of 67 pence per Placing Share (the "Placing Price") to raise a total of £20,000,000 (before expenses) (the "Placing").

 

The proceeds of the Placing will be applied towards paying part of the consideration for the acquisition of Metro Rod Limited, as announced earlier today (the "Acquisition").

 

The Placing is conditional, inter alia, on the approval of shareholders at a general meeting of the Company to be held on 10 April 2017 (the "General Meeting") of resolutions to provide authority to the Directors to issue and allot the Placing Shares and to approve the Acquisition for the purposes of rule 14 of the AIM Rules for Companies. The Placing is also conditional on admission of the Placing Shares (and the re-admission of the Existing Ordinary Shares) to trading on AIM ("Admission"). Application will be made for the Placing Shares to be admitted (and the Existing Ordinary Shares to be re-admitted) to trading on AIM and it is expected that Admission will take place on 11 April 2017.

 

The Placing Shares will represent, in aggregate, approximately 38.4 per cent. of the Company's issued ordinary share capital as enlarged by the issue of the Placing Shares.

 

The Placing Shares will rank pari passu in all respects with the Existing Ordinary Shares, including the right to receive dividends and other distributions declared, made or paid in respect of the Ordinary Shares. For the avoidance of doubt, the Placing Shares will not be eligible to receive the dividend announced in the Group's annual report and accounts for the year to 31 December 2016.

 

Further details regarding the background to the Acquisition and the Placing can be found in the Company's announcement made earlier today. .

 

Directors' participation

 

All of the Directors are participating in the Placing on identical terms to the Placees. The Directors have agreed to subscribe, in aggregate, for 16,671,459 Placing Shares at the Placing Price as follows:

 

 

Current Holding

 

At Admission

Director

Number of Ordinary Shares held

Percentage of Ordinary Shares in issue

Number of Placing Shares

Number of Ordinary Shares held

Percentage of Ordinary Shares in issue

Stephen Hemsley

13,000,431

27.15

7,462,686

20,463,117

26.33

Nigel Wray

14,080,434

29.41

7,462,686

21,543,120

27.71

David Poutney

606,060

1.27

1,417,910

2,023,970

2.60

Julia Choudhury

1,010,229

2.11

194,029

1,204,258

1.55

Tim Harris

999,762

2.09

59,222

1,059,284

1.36

Robin Auld

908,882

1.90

37,313

946,195

1.22

Rob Bellhouse

45,455

0.09

37,313

82,768

0.11

Total

30,651,253

64.02

16,671,459

47,322,712

60.88

 

The Directors are treated as related parties of the Company under the AIM Rules. The Directors' participation in the Placing is therefore treated as a related party transaction pursuant to rule 13 of the AIM Rules. Accordingly, the Company's nominated adviser, Allenby Capital, considers that the terms of the Directors' participation in the Placing are fair and reasonable insofar as Shareholders are concerned.

 

Total Voting Rights

The Placing is conditional, among other things, upon Admission becoming effective. Following Admission, the Company's issued ordinary share capital will consist of 77,732,033 Ordinary Shares, with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 77,732,033. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Unless otherwise defined, the defined terms used in this Announcement shall have the same meaning (unless the context otherwise requires) as ascribed to them in the "Definitions" and "Technical Glossary" section in the Admission Document published by the Company earlier today.

 

**ENDS**

Enquiries:

Franchise Brands plc + 44 (0) 800 012 6462

Stephen Hemsley, Executive Chairman

Julia Choudhury, Corporate Development Director

 

MHP Communications +44 (0) 20 3128 8100(Financial PR) franchisebrands@mhpc.com

Katie Hunt / Hannah Winter

 

Allenby Capital Limited +44 (0) 20 3328 5656(Nominated Adviser and Joint Broker)

Jeremy Porter/ James Thomas / Liz Kirchner

 

Dowgate Capital Stockbrokers +44 (0)1293 517744

(Joint Broker)

James Serjeant / Neil Badger

 

IMPORTANT NOTICE

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY, IS NOT INTENDED TO AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO PURCHASE OR SUBSCRIBE FOR, UNDERWRITE, SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE, SELL, ACQUIRE, DISPOSE OF THE PLACING SHARES OR ANY OTHER SECURITY IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN ANY JURISDICTION IN WHICH, OR TO ANY PERSONS TO WHOM, SUCH OFFERING, SOLICITATION OR SALE WOULD BE UNLAWFUL.

Allenby Capital Limited is authorised and regulated in the United Kingdom by the Financial Conduct Authority ("FCA") and is acting exclusively for the Company in connection with the Acquisition, Placing and Admission and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice to any other person in relation to the Acquisition, Placing, Admission and/or any other matter referred to in this Announcement.

Dowgate Capital Stockbrokers Limited is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for the Company in connection with the Acquisition, Placing and Admission and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice to any other person in relation to the Acquisition, Placing, Admission and/or any other matter referred to in this Announcement.

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Allenby Capital or Dowgate Capital or any of their respective affiliates or any of their respective directors, officers, employees, advisers or representatives (collectively, "Representatives") as to or in relation to the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefor is expressly disclaimed.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROISEESADFWSEFD
Date   Source Headline
4th Apr 20243:02 pmRNSHolding(s) in Company
20th Feb 20242:45 pmRNSCapital Markets Day
18th Jan 20247:00 amRNSCapital Markets Day
18th Jan 20247:00 amRNSTrading Update
16th Jan 20245:12 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSInvestor presentation
15th Nov 20233:11 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSQ3 Trading Update
4th Sep 20237:00 amRNSBoard and management update
4th Aug 20237:00 amRNSDirector/PDMR Shareholding and Grant of Options
27th Jul 20237:01 amRNSAppointment of Chief Financial Officer
27th Jul 20237:00 amRNSInterim Results
25th Jul 20231:51 pmRNSInvestor Presentation via Investor Meet Company
5th Jul 20237:00 amRNSNotice of Interim Results
26th Jun 20237:00 amRNSShare Purchase Programme
1st Jun 20237:00 amRNSDirector/PDMR Shareholding
18th May 202310:10 amRNSHolding(s) in Company
10th May 20235:54 pmRNSGrant of options & director holdings
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20235:00 pmRNSTotal Voting Rights
25th Apr 20234:09 pmRNSHolding(s) in Company
24th Apr 20231:55 pmRNSHolding(s) in Company
20th Apr 20239:33 amRNSResult of GM, Completion of Acquisition and TVR
18th Apr 20231:56 pmRNSResult of AGM
18th Apr 20237:00 amRNSAGM Statement and Trading Update
14th Apr 202312:10 pmRNSDirector/PDMR Shareholding
4th Apr 202312:08 pmRNSResult of Placing and Notice of GM
3rd Apr 20235:52 pmRNSProposed Acquisition and Launch of ABB
20th Mar 20237:00 amRNSPosting of Annual Report and Notice of AGM
13th Mar 202312:24 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSRule 19.6(c) confirmation
9th Mar 20234:54 pmRNSDividend Declaration and AGM date
9th Mar 20237:00 amRNSFinal Results
8th Mar 20235:20 pmRNSHolding(s) in Company
23rd Feb 20237:00 amRNSAnnual Results Presentation
22nd Feb 20237:00 amRNSAppointment of Joint Corporate Broker
25th Jan 20237:00 amRNSNotice of Results
23rd Jan 20237:00 amRNSNotice of Electronic Communications
13th Jan 20237:00 amRNSCapital Markets Day
12th Jan 20237:00 amRNSTrading Update
23rd Dec 20227:00 amRNSShare Purchase Programme
30th Nov 20225:00 pmRNSTotal Voting Rights
30th Nov 20224:40 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSExercise of share options, PDMR notification & TVR
1st Nov 20221:41 pmEQSFranchise Brands benefiting from strong contributions by Filta North America and Metro Rod
27th Oct 20227:00 amRNSQ3 Trading Update
3rd Oct 20227:00 amRNSAppointment of Interim CFO and grant of options
12th Sep 20227:00 amRNSAppointment of Non-Executive Director
26th Jul 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.